Thursday, July 9, 2026

Patent intelligence · US

US 11795192

Antimicrobial compounds, compositions, and uses thereof

granted A61KA61K9/0014A61K9/0034A61K9/0046
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 17
Applicant portfolio 18
Patent details — US 11795192
Jurisdiction
US
Status
granted
Grant date
Oct 24, 2023
Expiration
Oct 19, 2043
Claims
21
CPC classes
A61K, A61K9/0014, A61K9/0034, A61K9/0046
View on Google Patents ↗

Quick answer

US 11795192 (Antimicrobial compounds, compositions, and uses thereof) is held by Lakewood Amedex, Inc.. Status: granted. Granted Oct 24, 2023. Expires Oct 19, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
21
CPC classes
A61K, A61K9/0014, A61K9/0034, A61K9/0046, A61K9/0078, A61K9/06

More from Lakewood Amedex, Inc.

Related pharmaceutical patents in our USPTO index.

  1. US 12156883

    Bisphosphocin gel formulations and uses thereof

    Lakewood Amedex, Inc. · Expires Nov 28, 2044

    granted
  2. US 12054509

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Expires Aug 1, 2044

    granted
  3. US 12030908

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Expires Jul 4, 2044

    granted
  4. US 11377468

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Expires Jun 30, 2042

    granted
  5. US 11123357

    Methods and compositions for treating oral mucositis

    Lakewood Amedex, Inc. · Expires Sep 16, 2041

    granted
  6. US 11096954

    Bisphosphocin gel formulations and uses thereof

    Lakewood Amedex, Inc. · Expires Aug 19, 2041

    granted
  7. US 10981943

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Expires Apr 15, 2041

    granted

Frequently asked questions

What is US patent 11795192?

US 11795192 (Antimicrobial compounds, compositions, and uses thereof) is held by Lakewood Amedex, Inc.. Status: granted. Granted Oct 24, 2023. Expires Oct 19, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11795192?

Lakewood Amedex, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 18 pharmaceutical patents for this assignee.

When does US 11795192 expire?

Our index shows an expiration date of Oct 19, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.